Frankfurt - Delayed Quote EUR

Redcare Pharmacy NV (RDC.F)

125.20
+0.10
+(0.08%)
At close: May 9 at 8:33:16 PM GMT+2
Loading Chart for RDC.F
  • Previous Close 125.10
  • Open 124.10
  • Bid 124.70 x --
  • Ask 125.30 x --
  • Day's Range 123.40 - 125.20
  • 52 Week Range 95.95 - 170.90
  • Volume 168
  • Avg. Volume 852
  • Market Cap (intraday) 2.517B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -2.27
  • Earnings Date Jul 29, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 168.64

Redcare Pharmacy NV operates in online pharmacy business in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. It provides prescription and non-prescription over-the-counter pharmaceuticals, beauty and personal care products, and food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. Redcare Pharmacy NV was founded in 2001 and is headquartered in Sevenum, the Netherlands.

www.redcare-pharmacy.com

1,827

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RDC.F

View More

Performance Overview: RDC.F

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

RDC.F
5.65%
DAX P (^GDAXI)
18.03%

1-Year Return

RDC.F
0.08%
DAX P (^GDAXI)
25.75%

3-Year Return

RDC.F
38.07%
DAX P (^GDAXI)
75.62%

5-Year Return

RDC.F
61.76%
DAX P (^GDAXI)
115.50%

Compare To: RDC.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RDC.F

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    2.52B

  • Enterprise Value

    2.59B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.06

  • Price/Book (mrq)

    5.20

  • Enterprise Value/Revenue

    1.09

  • Enterprise Value/EBITDA

    91.88

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.92%

  • Return on Assets (ttm)

    -2.36%

  • Return on Equity (ttm)

    -9.60%

  • Revenue (ttm)

    2.53B

  • Net Income Avi to Common (ttm)

    -48.48M

  • Diluted EPS (ttm)

    -2.27

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    184.82M

  • Total Debt/Equity (mrq)

    50.00%

  • Levered Free Cash Flow (ttm)

    -311.5k

Research Analysis: RDC.F

View More

Company Insights: RDC.F

Research Reports: RDC.F

View More

People Also Watch